FIELD: medicine; pharmacology.
SUBSTANCE: composition contains lidocaine concentrated approximately 5 to 12.5 wt % as medical product and bioadhesive carrier including swelling, but water-insoluble cross-linked polymer of polycarboxilic acid, providing prolonged release of the agent. Furthermore, the invention refers to method of reduction or simplification of uterus rhythm disturbance including introduction of declared composition to the patient requiring treatment.
EFFECT: reduction or simplification of uterus rhythm disturbance due to normalisation of abnormal or undesirable uterus contraction.
11 cl, 33 ex
Authors
Dates
2009-02-10—Published
2002-10-28—Filed